Literature DB >> 6024563

Topics in clinical medicine. Complement levels in disease.

A S Townes.   

Abstract

Mesh:

Substances:

Year:  1967        PMID: 6024563

Source DB:  PubMed          Journal:  Johns Hopkins Med J        ISSN: 0021-7263


× No keyword cloud information.
  9 in total

1.  Lupus glomerulitis and renal vein thrombosis.

Authors:  G S Bridi; R A Frayha
Journal:  Br Med J       Date:  1976-03-27

2.  Examination of complement C3 metabolism in rheumatoid arthritis using 2-dimensional immunoelectrophoresis.

Authors:  M F Shadforth; D C McNaughton
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

3.  Standardized, automated procedure for measurement of serum hemolytic complement activity.

Authors:  I Olitzky
Journal:  Appl Microbiol       Date:  1968-11

4.  Complement metabolism in rheumatoid arthritis. I. Longitudinal studies.

Authors:  J M Versey; J R Hobbs; P J Holt
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

Review 5.  Complement and autoimmunity.

Authors:  Eleonora Ballanti; Carlo Perricone; Elisabetta Greco; Marta Ballanti; Gioia Di Muzio; Maria Sole Chimenti; Roberto Perricone
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

6.  Serum complement in chronic liver disease.

Authors:  B J Potter; A M Trueman; E A Jones
Journal:  Gut       Date:  1973-06       Impact factor: 23.059

7.  The serum concentration of the third component of complement beta-1C-beta-1A in liver disease.

Authors:  R A Fox; F J Dudley; S Sherlock
Journal:  Gut       Date:  1971-07       Impact factor: 23.059

8.  In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia.

Authors:  L D Petz; D J Fink; E A Letsky; H H Fudenberg; J Müller-Eberhard
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

Review 9.  Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases.

Authors:  Silvia Cavalli; Paola Adele Lonati; Maria Gerosa; Roberto Caporali; Rolando Cimaz; Cecilia Beatrice Chighizola
Journal:  Front Pharmacol       Date:  2022-02-15       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.